Using strong information integration and analysis capabilities to provide strategic and operational solutions in the whole life cycle of product development from pre-clinical to post-marketing.
• Planning and construction of nuclear medicine department
• Consultation on registration and clinical trial regulations
• GCP/GLP consultation and audit
• Corrective and Preventive Actions (CAPA)
• GCP quality system construction
• Multinational declaration/clinical development strategies such as China and the United States
• Evaluation and consultation of new drug research and development
Address：Ping An Fortune Center, Lize Financial Business District of Beijing
